Zimbabwe has rejected a substantial US health deal worth $367m (272 million pounds) spanning five years because of Washington's insistence on confidential information.
The decision was revealed after a internal memorandum dated December was disclosed, which showed President Emmerson Mnangagwa deemed the agreement was "skewed".
An official spokesperson has since clarified that the US was seeking health data for research and commercial gain but refused to share the benefits from future treatments.
"We will now turn to the challenging and unfortunate process of winding down our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy said the US had donated over $1.9bn as health assistance to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has appealed for further talks to reach a agreement acceptable to all parties so the country's vital HIV treatment initiative can proceed.
Wider Implications
Zimbabwe's decision comes after a comparable situation in Kenya, where a high court halted a related health funding agreement following concerns were filed about the safety of citizens' health data.
Since returning to the presidency last year, US President Donald Trump has drastically cut overseas assistance and closed the US Agency for International Development (USAID).
USAID had managed aid for the American government, but Trump claimed its expenditure was "inefficient" and his administration was seeking government-to-government agreements to enhance openness and accountability.
As per statements, Sixteen African countries have to date signed similar health pacts, constituting over $18.3bn of fresh investment.
Details of the Declined Agreement
This assistance for Zimbabwe would have funded "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this cooperation would have delivered immense advantages for Zimbabwean communities, especially the 1.2 million men, women and children presently receiving antiretroviral therapy via American-funded initiatives," Tremont said.
However, official spokesman Nick Mangwana said the proposed deal was "unfair".
"Our nation was requested to provide its biological resources and data indefinitely, with no equivalent guarantee of access to any medical innovations – like vaccines, diagnostics, or treatments – that might result from that provided information," his statement read.
"Effectively, our nation would provide the basic resources for medical research with no certainty that the final treatments would be available to our people should a new disease outbreak arise."
Sovereignty and International Frameworks
Mangwana further noted that the American exit from the global health body and its pursuit of bilateral health agreements were disrupting structures previously set up via the global health agency.
Mangwana cited its Pathogen Access and Benefit Sharing scheme designed to deal with potential global health emergencies.
"This system is designed to guarantee that when a country provides its samples, the resulting advantages – including vaccines and treatments – are distributed fairly, not monopolised solely by those with the funds to develop them."
The government's concerns regarding the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.
"We welcome ongoing discussions with our US partners on how future co-operation could be arranged in a manner that honours the independence and dignity of each country."
Medical Community Reaction
Medical experts said it understood the government's concerns, but urged that negotiations should continue considering much of the country's Aids initiatives relied on external financing.
"In cases where specific concerns exist, such as those involving data governance or agreement terms, these can frequently be addressed through detailed discussion and mutually agreed protections," it said.
The halted deal underscores the complex debate between accepting vital international aid and protecting national sovereignty in an ever more interconnected world.